Novavax (NVAX) Non Operating Investment Income (2011 - 2013)
Novavax (NVAX) recorded quarterly Non Operating Investment Income of $267000.0 in Q2 2013, down 46.81% quarter-over-quarter from $502000.0 in Q4 2012, and up 364.36% on a YoY basis from $57498.9 in Q2 2012.
Novavax (NVAX) Non Operating Investment Income (2011 - 2013) Analysis & Trends
Novavax's Non Operating Investment Income history runs 3 years deep, the most recent figure standing at $267000.0 for Q2 2013.
- In Q2 2013, Non Operating Investment Income rose 364.36% year-over-year to $267000.0; the TTM figure through Dec 2013 stood at $769000.0 (up 661.39% YoY), while the FY2013 annual figure was $267000.0, up 164.36% from the prior year.
- Non Operating Investment Income was $267000.0 for Q2 2013 at Novavax, down from $502000.0 in the prior quarter.
- In the past five years, Non Operating Investment Income ranged from a high of $1.3 million in Q2 2011 to a low of -$401000.0 in Q3 2012.
- Historically, Non Operating Investment Income has averaged $229285.7 across 3 years, with a median of $101000.0 in 2012.
- The sharpest annual moves came in 2012 and 2013: Non Operating Investment Income sank 107.75% in 2012, then soared 364.36% in 2013.
- A 3-year view of Non Operating Investment Income shows it stood at $1.3 million in 2011, then tumbled by 61.5% to $502000.0 in 2012, then slumped by 46.81% to $267000.0 in 2013.
- The last three Non Operating Investment Income figures came in at $267000.0 (Q2 2013), $502000.0 (Q4 2012), and -$401000.0 (Q3 2012), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 235,807.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 230,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Novavax | 1.49 Bn | 931.98 Mn | 108.82 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2013 | 267,000.00 |
| Jun 30, 2013 | 267,000.00 |
| Dec 31, 2012 | 502,000.00 |
| Dec 31, 2012 | 502,000.00 |
| Sep 30, 2012 | -401,000.00 |
| Sep 30, 2012 | -401,000.00 |
| Jun 30, 2012 | -101,000.00 |
| Jun 30, 2012 | -101,000.00 |
| Mar 31, 2012 | 101,000.00 |
| Mar 31, 2012 | 101,000.00 |
| Jun 30, 2011 | 1.30 Mn |
| Jun 30, 2011 | 1.30 Mn |
| Mar 31, 2011 | -67,000.00 |
| Mar 31, 2011 | -67,000.00 |